In this context, our results shed light on a potential intracellular maldistribution of TFAM in sepsis and endotoxemia resulting in decreased intramitochondrial TFAM, although its source, i.e., extramitochondrial TFAM, is conserved or even increased. The gene discussed is TFAM; the disease is serum lipopolysaccharide activity.